Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11242 clinical trials
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Drugs used in chemotherapy, such as CPX-351, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

myeloid leukemia
daunorubicin
treatment related aml
myelodysplastic syndrome
myelodysplasia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies.

waldenstrom's macroglobulinemia
platelet transfusion
igm level
myd88 gene mutation
neutrophil count
  • 0 views
  • 16 Feb, 2024
  • 2 locations
  • 0 views
  • 06 Dec, 2023
  • 2 locations
trial1234567890-

tegvscdkcmldcdhcgvbnm,

  • 0 views
  • 28 Sep, 2023
  • 1 location
  • 0 views
  • 18 Dec, 2023
  • 1 location
A Daily-Activity-Focused, Strategy-Based Educational Programme for Informal Dementia Carers

This study will assess the impact of the Dementia Carer Education Programme on the caregiving burden of informal dementia carers.Ninety informal dementia carers along with their care-recipients will be recruited and randomised to the experimental and control groups. All recruited dementia carers in the experimental group will receive the Dementia …

  • 0 views
  • 16 Jun, 2025
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

This is a phase III randomized clinical trial of definitive radiotherapy plus EGFR blocker nimotuzumab versus radiotherapy plus cisplatin(CCRT) for nasopharyngeal carcinoma (NPC) patients with favorable response to induction chemotheray(IC), determining whether radiotherapy combined with nimotuzumab was non-inferior to CCRT and may provide new evidence for individualized comprehensive treatment of …

epstein-barr virus dna
EGFR
induction chemotherapy
nasopharyngeal carcinoma
nimotuzumab
  • 0 views
  • 16 Feb, 2024
  • 1 location
Pembrolizumab Plus Paclitaxel Cisplatin Followed by Surgery for Locally Advanced ESCC

The purpose of this study is to observe and evaluate the efficacy and safety of pembrolizumab plus paclitaxel, cisplatin followed by Da Vinci robot radical surgery for locally advanced esophageal squamous cell carcinoma.

squamous cell carcinoma of esophagus
urine test
pembrolizumab injection
serum pregnancy test
cisplatin
  • 0 views
  • 16 Feb, 2024
  • 1 location
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

To compare the effectiveness and toxicity of nedaplatin versus cisplatin in induction chemotherapy combined with concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.

docetaxel
nasopharyngeal carcinoma
induction chemotherapy
fluorouracil
chemoradiotherapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

Prospective phase I study to evaluate the maximum tolerated dose (MTD) of SBRT for thoracic re-irradiation. Dose limiting toxicity will be pneumonitis G3. The potential advantage of the dose escalation planned in this study is the delivery of an ablative dose to radically treat patients with inoperable local relapse, without …

pulmonary metastasis
tumor recurrence
pneumonitis
reirradiation
stereotactic body radiation therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location